Streetbeat News

Products Services

CRM

Inclusively and Salesforce have expanded their partnership to enhance Salesforce's accessibility resources and support for employees. This collaboration introduces an AI-enabled interface designed to help Salesforce employees find workplace accommodations and support more easily and confidentially. The AI tool, previously piloted by Salesforce, aims to improve productivity and fulfillment by offering personalized solutions. It also provides Salesforce's Office of Accessibility with valuable feedback on the usage of accessibility benefits.

Portfolio Pulse from Benzinga Newsdesk

May 07, 2024 | 12:08 pm

SHEL

WEX

WEX has reached an agreement with Shell to manage Shell's commercial fleet fuel cards in North America, enhancing their 2018 partnership. This deal leverages WEX's software and payments expertise alongside Shell's extensive brand presence, aiming to provide comprehensive solutions for commercial fleets across the United States, Canada, and Mexico. The collaboration covers a range of Shell Fleet Cards, including new electric vehicle payment solutions, and underscores WEX's role as a leader in commercial mobility solutions.

Portfolio Pulse from Benzinga Newsdesk

May 07, 2024 | 12:06 pm

SGMT

Sagimet Biosciences Inc. (NASDAQ:SGMT) announced its Phase 2b FASCINATE-2 study data of denifanstat, a novel fatty acid synthase inhibitor for MASH, will be presented at the EASL International Liver Congress 2024. The study shows significant fibrosis improvement and MASH resolution.

Portfolio Pulse from Benzinga Newsdesk

May 07, 2024 | 12:05 pm

CART

UBER

Instacart and Uber have announced a partnership that will integrate Uber Eats restaurant delivery services into the Instacart platform, allowing Instacart customers to order food from restaurants directly through Instacart's app.

Portfolio Pulse from Benzinga Newsdesk

May 07, 2024 | 12:04 pm

MTNB

Matinas BioPharma Holdings, Inc. (MTNB) announced that its Chief Medical Officer, James J. Ferguson, M.D., will present two abstracts at the ASGCT 27th Annual Meeting, showcasing the effectiveness of its LNC platform in delivering small oligonucleotides. The presentations will cover data from ex vivo, in vitro, and in vivo studies demonstrating the LNC platform's potential in targeted delivery for therapeutic purposes, including a focus on inflammatory disease models.

Portfolio Pulse from Benzinga Newsdesk

May 07, 2024 | 12:04 pm

HAO

Haoxi Health Technology Limited (HAO), a Beijing-based online marketing solution provider, announced a rebate agreement with Jinan Yanling Biotechnology Co., Ltd. and its affiliates for advertising services. The agreement involves a minimum spend of $7 million on ByteDance's platforms, including Jinri Toutiao, Douyin, and Xigua Video, to enhance Yanling's exposure and market reach. This partnership aims to leverage ByteDance's extensive user base for targeted advertising, offering rebates based on various performance metrics.

Portfolio Pulse from Benzinga Newsdesk

May 07, 2024 | 12:02 pm

CMND

Clearmind (CMND) has secured exclusive global rights to develop, manufacture, and commercialize innovative compounds invented by Professors Rami Yaka, Ahmed Masaewa, and Avi Priel from The Hebrew University.

Portfolio Pulse from Benzinga Newsdesk

May 07, 2024 | 11:48 am

CMND

Clearmind Medicine has entered into an exclusive patent licensing agreement with Yissum Research Development Company. This agreement grants Clearmind exclusive rights to develop, manufacture, and commercialize novel compounds aimed at treating PTSD and other mental health disorders.

Portfolio Pulse from Benzinga Newsdesk

May 07, 2024 | 11:47 am

BYDDF

BYDDY

NIO

Nio has partnered with BYD, backed by Warren Buffett, to launch a budget-friendly EV brand named 'Onvo', aiming to compete with Tesla's Model Y. This partnership allows Nio to source batteries from BYD, alongside its current supplier CATL, and another provider CALB for different versions of the Onvo EV. This move is part of a broader strategy to reduce costs and compete more effectively in the fiercely competitive Chinese EV market. BYD, having surpassed Tesla in global EV production, is focusing on making EVs more affordable than gasoline vehicles.

Portfolio Pulse from Benzinga Neuro

May 07, 2024 | 11:44 am

AGEN

Agenus is set to release updated Phase 1 and 2 data later this year for its ongoing studies in melanoma, lung cancer, sarcoma, and pancreatic cancer. This announcement indicates significant progress in the company's oncology research and development efforts.

Portfolio Pulse from Benzinga Newsdesk

May 07, 2024 | 11:41 am